Navigation Links
University of Michigan's Zell Lurie Institute Awards $112,000 to Promising Student Startups in 30th Annual Business Plan Competition and Dare to Dream Grant Program
Date:2/25/2013

ANN ARBOR, Mich., Feb. 25, 2013 /PRNewswire-USNewswire/ -- The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan's Stephen M. Ross School of Business today announced today the winners of the 30th Michigan Business Challenge and recipients of the Applebaum Dare to Dream Grants and Mayleben Family Venture Shaping Grants. The business plan competition and grant programs, which recognize promising student-led startups, provided grants and funding totaling $112,000 this year.

"We are developing the next generation of serial entrepreneurs and venture investors, through a combination of education and intense action-based learning experiences aimed at the discovery, shaping, formation, investment, and growth of new ventures," said Tim Faley , managing director of the Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies. "For decades, the Michigan Business Challenge and Dare to Dream grant programs have been helping us do this and we are always impressed with the quality and promise of the businesses and student entrepreneurs campus-wide that get involved."

Michigan Business Challenge

2013 marks the 30th anniversary of the Michigan Business Challenge. The four-month, multi-round competition began in the fall with nearly 200 students from across the University representing 72 teams—almost double the number of participants in last year's program.

The 72 teams were narrowed down over the course of two rounds of competition to nine semi-finalist teams. On Friday, February 22, the semi-finalist teams were weeded out further to a field of four finalists that presen
'/>"/>

SOURCE Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
2. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
3. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
4. Guangzhous Sun Yat-sen University Cancer Center Debuts MOSAIQ in the Chinese Platform
5. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
6. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
7. Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients
8. Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States
9. University of Michigans Wolverine Venture Fund Participates in $25 Million Series D Investment in Sonitus Medical
10. Oregon State University Launches New Online Learning System For Pharmacy Managers
11. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium Research ... market intelligence, the United States ... device markets will expand moderately through 2022, with ... In particular, increasing interest in drug-eluting beads (DEBs) ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01940411/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-End-Users.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology STUDY OBJECTIVES ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... 1, 2010 Elsevier, the leading,publisher of scientific, technical and ... the newly formed Global Sales &,Customer Marketing group in the Science ... Government, Books and Corporate,Markets, effective 1 July. , ... O,Malley,s appointment ...
... June 30 Dendreon Corporation (Nasdaq: ... Medicaid Services (CMS) today initiated a National Coverage Analysis (NCA) ... treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) ... new therapeutic class known as autologous cellular immunotherapies. , ...
Cached Medicine Technology:Elsevier Appoints Martin O'Malley as Managing Director of New Global Sales Group in Science & Technology Division 2Elsevier Appoints Martin O'Malley as Managing Director of New Global Sales Group in Science & Technology Division 3Elsevier Appoints Martin O'Malley as Managing Director of New Global Sales Group in Science & Technology Division 4Dendreon Statement on CMS National Coverage Analysis 2Dendreon Statement on CMS National Coverage Analysis 3Dendreon Statement on CMS National Coverage Analysis 4
(Date:7/9/2014)... acute episodes of low back pain are not linked ... wind direction and precipitation. Findings published in Arthritis ... College of Rheumatology (ACR), indicate that the risk of ... or wind gusts, but was not clinically significant. ... everyone experiences low back pain at some point in ...
(Date:7/9/2014)... types of cancer sends the protein factories in our ... uncontrolled growth, new research suggests. , Scientists at The ... responsible for ratcheting up activity of the endoplasmic reticulum ... blocks cancer cells need to keep growing. , A ... the flow of messages to the endoplasmic reticulum telling ...
(Date:7/9/2014)... found that fecal transplantation is effective and safe for ... is the result of a study led by Colleen ... Gastrointestinal Medicine at The Women,s Medicine Collaborative. The study ... of print in the American Journal of Gastroenterology ... diff , has increased to epidemic proportions over the ...
(Date:7/9/2014)... DALLAS July 9, 2014 There has been ... at UT Southwestern Medical Center using MyChart, the online, ... radiology results, communicate with their healthcare providers, schedule appointments, ... number of patients actively using MyChart each ... each year increased more than 10-fold, according to a ...
(Date:7/9/2014)... of Allergy and Infectious Diseases (NIAID), part of ... early-stage clinical trial of CRS3123, an investigational oral ... ( C. difficile ) infection. CRS3123 (previously known ... C. difficile growth while sparing normal intestinal bacteria. ... to 30 healthy men and women ages 18 ...
Breaking Medicine News(10 mins):Health News:Low back pain? Don't blame the weather 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2
... WeissComm Group today announced the acquisition of ... company founded by Bob Pearson , who will ... that it has signed a strategic alliance with Rule ... and training. Pearson will continue to operate and grow this ...
... May 27 eCardio Diagnostics ( www.ecardio.com ... is a finalist for the Ernst & Young Entrepreneur ... Houston & Gulf Coast Area Program. According to ... who demonstrate extraordinary success in the areas of innovation, ...
... 27 Autism is a neurobiological condition which is ... some health insurance companies, especially HMOs, fail to cover ... Wellspring, a leader in autism treatment, is excited to ... with their CA health insurance plan to cover autism ...
... term follow-up indicates modest efficacy in primary and ... Ceregene, Inc. today reported additional clinical data ... CERE-120 in 58 patients with advanced Parkinson,s disease. ... the neurotrophic factor, neurturin, to Parkinson,s disease patients ...
... 27 The incidence of cardiovascular disease is ... smoking and other cardiac ailments. Each year cardiovascular ... 48 per cent of all mortalities in Europe.(Logo: ... cardiac rhythm management (CRM) market offers significant growth ...
... laser therapy, is a new treatment that provides proven pain relief and ... offered by The Laser Pain Management Center in Western Massachusetts. , ... ... adverse affect on every aspect of daily life. Low level laser therapy ...
Cached Medicine News:Health News:WeissComm Group Acquires Common Sense Media Group, Appoints Founder Bob Pearson Chief Technology and Media Officer to Help Clients Evaluate and Optimize Social Media 2Health News:WeissComm Group Acquires Common Sense Media Group, Appoints Founder Bob Pearson Chief Technology and Media Officer to Help Clients Evaluate and Optimize Social Media 3Health News:WeissComm Group Acquires Common Sense Media Group, Appoints Founder Bob Pearson Chief Technology and Media Officer to Help Clients Evaluate and Optimize Social Media 4Health News:eCardio Chief Executive Officer Larry Lawson Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Finalist in the Houston & Gulf Coast Area Program 2Health News:Wellspring Coordinates With CA Health Insurance Plans to Pay for Autism Treatments 2Health News:Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease 2Health News:Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease 3Health News:Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease 4Health News:Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease 5Health News:Advanced Technologies Pump Growth Into European Cardiac Rhythm Management Market, Affirms Frost & Sullivan 2Health News:Advanced Technologies Pump Growth Into European Cardiac Rhythm Management Market, Affirms Frost & Sullivan 3Health News:Advanced Technologies Pump Growth Into European Cardiac Rhythm Management Market, Affirms Frost & Sullivan 4Health News:New Non-Surgical Laser Treatment Helps Patients Live Pain Free 2Health News:New Non-Surgical Laser Treatment Helps Patients Live Pain Free 3
... generators are meeting the clinical needs ... and anesthesiologists. And, they are of ... from Medtronic.,Effective pacing with the adjustment ... for quick battery changes. Both ...
... CardioVad is a unique left ventricular assist device ... It is being used in a small group ... as part of an FDA-approved Feasibility Study. The ... the external power source for minutes or hours. ...
... Inc. has introduced the world's first minimally-invasive ... 10626 Epicardial Lead Implant Tool, which has ... States, will expand the options available to ... 5071 lead on the heart during pacemaker ...
The Schiller treadmill ergometer is designed for stress tests, sports medicine and cardiology. It is equipped and tested with the latest safety system and has been manufactured under the stringent qu...
Medicine Products: